Month: February 2010

Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, announces that on 22 February 2010, 1,783 ordinary shares of 2p each in the Company (the “Ordinary Shares”) were allotted in a board meeting to satisfy an exercise of options exercised under the Company’s SAYE scheme. Download Report 

Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, announces that on 8 February 2010, 66,723 ordinary shares of 2p each in the Company (the “Ordinary Shares”) were allotted in a board meeting to satisfy an exercise of options. Download Report